480 Catheter pulmonary vein ablation vs. medical therapy or atrioventricular node ablation and resynchronization in patients with atrial fibrillation and heart failure: a systematic review and meta-analysis

医学 心房颤动 心脏病学 内科学 心房扑动 心力衰竭 心脏再同步化治疗 导管消融 射血分数 随机对照试验 优势比 观察研究 置信区间 危险系数 烧蚀 子群分析
作者
Gaetano Liccardo,Francesco Cannata,Mauro Chiarito,Sara Bombace,Marta Maccallini,Alessandro Villaschi,Giuseppe Pinto,Fabio Fazzari,Daniela Pini,Renato Maria Bragato,Gianluigi Condorelli,Riccardo Cappato,Giulio G Stefanini
出处
期刊:European Heart Journal Supplements [Oxford University Press]
卷期号:23 (Supplement_G)
标识
DOI:10.1093/eurheartj/suab127.013
摘要

Abstract Aims Atrial fibrillation (AF) and heart failure (HF) are increasing in prevalence worldwide and, when present altogether, are associated with significant mortality and morbidity. Several and recent randomized clinical trials have reported an improvement of clinical outcomes in patients with HF and AF with catheter ablation. To provide a comprehensive and updated synthesis of effect estimates of the available randomized and observational clinical trials comparing pulmonary vein isolation with optimal medical therapy (rate or rhythm) or atrioventricular node ablation and resynchronization. Methods and results MEDLINE database was searched from inception to 4 March 2021 by two reviewers (F.C. and M.C.) for relevant studies. The following key words were used: ‘atrial fibrillation’, ‘heart failure’, ‘ablation’, ‘medical’, ‘drug’, ‘rate’, ‘rhythm’, ‘resynchronization’, and ‘atrial flutter’. The co-primary outcomes were all-cause death and hospitalization for HF. A total of 16 studies enrolling 42 908 patients were included; of these, 9 were randomized controlled trials, 3 unadjusted observational studies, and 4 adjusted observational trials. Patients treated with catheter ablation had a statistically significant reduction for the risk of all-cause death {Figure on the left: odds ratio [OR]: 0.51, [95% confidence interval (CI): 0.31–0.84], P = 0.008, NNT 33} and hospitalization for HF [Figure on the right: OR: 0.52, (95% CI: 0.31–0.87), P 0.014, NNT 24]. Subgroup analysis confirmed these results only in HF with reduced ejection fraction subgroup. Meta-regression analyses showed a direct correlation between a higher burden of persistent/long-standing persistent AF and the positive impact of catheter ablation of AF. Moreover, the age of 70 years emerged as the cut-off age for a greater impact of catheter ablation. Conclusions Catheter ablation of AF is associated with a lower risk of all-cause death and HF hospitalizations in patients with AF and HF, as compared to medical therapy or atrioventricular node ablation and resynchronization. These results are mainly applicable for HF with reduced ejection fraction.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
达落完成签到,获得积分10
1秒前
1秒前
铁手无情完成签到,获得积分10
1秒前
风吹麦浪的应助被木葺采纳,获得10
1秒前
无奈亦瑶完成签到 ,获得积分10
1秒前
丘比特的应助被yefeng采纳,获得10
1秒前
2秒前
2秒前
酷酷的寄琴完成签到,获得积分10
3秒前
3秒前
4秒前
殷勤的紫槐的应助被李思超采纳,获得220
4秒前
JIAXI完成签到,获得积分10
4秒前
深情安青的应助被橙子采纳,获得10
4秒前
5秒前
光亮熠彤发布了新的文献求助10
5秒前
无极微光的应助被muzi采纳,获得20
5秒前
season完成签到,获得积分10
6秒前
6秒前
深情安青的应助被敏感寻真采纳,获得10
6秒前
7秒前
荔枝烨发布了新的文献求助10
7秒前
畅快的惜天完成签到,获得积分10
7秒前
7秒前
xiaojiu发布了新的文献求助10
8秒前
我是老大的应助被TZUYU采纳,获得10
8秒前
8秒前
9秒前
jiqiangqiang完成签到 ,获得积分10
9秒前
9秒前
隐形曼青的应助被weie采纳,获得10
9秒前
阳光雨堂发布了新的文献求助10
9秒前
9秒前
jingjing发布了新的文献求助10
10秒前
JamesPei的应助被TYF0715采纳,获得30
10秒前
无极微光的应助被小橙子采纳,获得20
10秒前
10秒前
fantasy的应助被stc采纳,获得10
11秒前
Qawsed发布了新的文献求助80
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170787
求助须知:如何正确求助?哪些是违规求助? 9563660
关于积分的说明 21771326
捐赠科研通 7762279
什么是DOI,文献DOI怎么找? 3430761
关于科研通互助平台的介绍 2554585
邀请新用户注册赠送积分活动 2475525